Literature DB >> 11025712

Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.

M Noguchi1, T A Stamey, J E McNeal, C M Yemoto.   

Abstract

PURPOSE: We compared pathological findings with prostate specific antigen (PSA) failure rates following radical prostatectomy for large volume cancers (6 cc or greater).
MATERIALS AND METHODS: A total of 191 men whose radical prostatectomy specimen had a cancer volume of 6 cc or greater were followed for a mean of 3.6 years (range 0.3 to 11.1) and 112 (58.6%) had PSA failure (PSA 0.07 ng./ml. or greater and increasing). Percent Gleason grade 4/5 (the Stanford modified Gleason scale), cancer volume, seminal vesicle invasion, regional lymph nodes, capsular penetration, positive surgical margin, location of the largest cancer in the peripheral or transition zone, prostate weight, patient age, preoperative PSA and clinical stage were analyzed using univariate and multivariate Cox proportional hazards analyses.
RESULTS: In univariate regression analysis percent Gleason grade 4/5, lymph node involvement, cancer volume, cancer location in the peripheral zone, capsular penetration and positive surgical margins were significant predictors of biochemical failure. Seminal vesicle invasion, preoperative serum PSA, patient age, prostate weight and clinical stage were not statistically significant. Forward stepwise, multivariate analysis showed that percent Gleason grade 4/5 (p <0.0001, relative risk ratio 2.498), cancer location in the peripheral zone (p = 0.0097, 1.887), cancer volume (p = 0.0157, 1.691) and lymph node involvement (p = 0.0317, 1. 666) were the only independent predictors of biochemical failure. When 52 men with organ confined, large volume prostate cancer were analyzed separately, univariate and multivariate analyses showed that only cancer location in the peripheral zone (p = 0.0021, relative risk ratio 13.473) and percent Gleason grade 4/5 (p = 0. 0449, 4.111) were independent predictors of failure.
CONCLUSIONS: Percent Gleason grade 4/5, cancer location in the peripheral zone, cancer volume and lymph node involvement have prognostic value in large volume prostate cancer. Cancer location in the peripheral zone and percent Gleason grade 4/5 are the most powerful predictors of biochemical failure in men whose cancer is 6 cc or greater and contained in the prostatic capsule. Preoperative serum PSA is not helpful in distinguishing biochemical failure rates in these large volume cancers whether they are organ confined or not.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11025712

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.

Authors:  Shahrokh F Shariat; Eduardo I Canto; Michael W Kattan; Kevin M Slawin
Journal:  Rev Urol       Date:  2004

2.  BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.

Authors:  Kevin M Slawin; Shahrokh Shariat; Eduardo Canto
Journal:  Rev Urol       Date:  2005

3.  An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.

Authors:  Kristen L Zakian; Hedvig Hricak; Nicole Ishill; Victor E Reuter; Steven Eberhardt; Chaya S Moskowitz; Amita Shukla-Dave; Liang Wang; Peter T Scardino; James A Eastham; Jason A Koutcher
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

4.  Analysis of Gleason grade and scores in 90 Nigerian Africans with prostate cancer during the period 1994 to 2004.

Authors:  U G Ugare; I E Bassey; P G Jibrin; I A Ekanem
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 5.  Screening for prostate cancer: an update.

Authors:  Shahrokh F Shariat; Peter T Scardino; Hans Lilja
Journal:  Can J Urol       Date:  2008-12       Impact factor: 1.344

6.  Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.

Authors:  Tim Joseph; David A McKenna; Antonio C Westphalen; Fergus V Coakley; Shoujun Zhao; Ying Lu; I-Chow Hsu; Mack Roach; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-28       Impact factor: 7.038

7.  Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI.

Authors:  Benedict Oerther; Moritz V Buren; Christina M Klein; Simon Kirste; Nils H Nicolay; Tanja Sprave; Simon Spohn; Deepa Darshini Gunashekar; Leonard Hagele; Lars Bielak; Michael Bock; Anca-L Grosu; Fabian Bamberg; Matthias Benndorf; Constantinos Zamboglou
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Prognostic factors for the development of biochemical recurrence after radical prostatectomy.

Authors:  Ahmed F Kotb; Ahmed A Elabbady
Journal:  Prostate Cancer       Date:  2011-06-15

9.  Determining relative importance of variables in developing and validating predictive models.

Authors:  Joseph Beyene; Eshetu G Atenafu; Jemila S Hamid; Teresa To; Lillian Sung
Journal:  BMC Med Res Methodol       Date:  2009-09-14       Impact factor: 4.615

10.  The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy.

Authors:  Sung Yong Cho; Young Deuk Choi
Journal:  World J Mens Health       Date:  2016-08-23       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.